Let’s Talk Covid-19 Long-Haul Syndrome, Symptoms May Continue for Months

 

Filmed live at the Hive, Atlanta, Georgia, on October 28, 2020. Dr. Baxter discusses so-called Covid-19 Long-Haul Syndrome. What are the long-term effects of being infected with coronavirus? Do I risk getting “long-haul” syndrome if I had a mild infection?

 

Dr. Baxter explains findings from an October 7, 2020 pre-print study (Long-term COVID-19 symptoms in a large unselected population). 46.1% had symptoms that persisted past 30 days. Most common: loss of smell or taste. More concerning: similar to symptoms from chronic fatigue syndrome. This begins to look like an auto-immune response to a virus.

 

Who’s most likely to get long-haul syndrome? Those with most severe COVID infection (hospitalization), those with difficulty breathing (shortness of breath) as an early symptom. Symptoms of long-haul syndrome include dizziness, brain fog, inability to concentrate, heart palpitations. Myocarditis.

 

Will I get “long-haul syndrome” if I had a mild case of COVID? This pre-print study showed 14.3% of patients with mild or asymptomatic infection had prolonged symptoms (lasting longer than 30 days). Phrased differently, you’re less likely to get “long-haul syndrome” if you have a mild case. How to get a mild case (if you have to get one at all) – reduce the viral load. How to reduce the viral load? #WearAMask and practice #NasalIrrigation.

 

Buzzy and VibraCool are FDA registered 510(k) cleared to Control pain associated with injections, venipuncture, IV starts, cosmetic injections and the temporary relief of minor injuries (muscle or tendon aches, splinters and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion and muscle tension.

 

Dr. Amy Baxter, MD, bio & more pain relief options here: https://paincarelabs.com/resources/power-over-pain/

 

Dr. Amy Baxter directs innovation, invention, and strategy for Pain Care Labs. Accomplishments include international thought leadership on pain management and acute opioid reduction, multiple NIH SBIR Fast-Tracks, eight issued patents, multiple first author textbook chapters and journal publications, and successful 510K FDA clearances. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, created and validated the BARF pediatric nausea scale cited in fifty studies, and founded Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED. On Homeolux Board of Directors. Also known for turning down Mr. Wonderful on Shark Tank.

    Back to Blog

    Related Articles

    Translating New Pain Management Research For Patients - Part 1 of 3 - Pain Care Labs

    Translating New Pain Management Research Part 1: What Is Pain?

    Staying Active & Pain Free As a Senior - Free Webinar - Pain Care Labs

    Get in Shape with Exercise and without the Pain! Baby boomers are...

    Handling Pain for the Student Athlete - Pain Care Labs

    An alternative option for pain care management and sport...